Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""multiple-sclerosis"" wg kryterium: Temat

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 173259
Tytuł:
No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort.
Autorzy:
König T; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Leutmezer F; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Berger T; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Zimprich A; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Schmied C; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Stögmann E; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Zrzavy T; Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.; Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 09; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 09.
Typ publikacji:
Journal Article
MeSH Terms:
C9orf72 Protein*/genetics
Multiple Sclerosis*/genetics
Humans ; Amyotrophic Lateral Sclerosis/genetics ; Austria ; Frontotemporal Dementia/genetics ; Multiple Sclerosis, Chronic Progressive/genetics ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exploring humanistic burden of fatigue in adults with multiple sclerosis: an analysis of US National Health and Wellness Survey data.
Autorzy:
Le HH; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. .
Ken-Opurum J; Cerner Enviza, North Kansas City, MO, USA.
LaPrade A; Cerner Enviza, North Kansas City, MO, USA.
Maculaitis MC; Cerner Enviza, North Kansas City, MO, USA.
Sheehan JJ; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Feb 01; Vol. 24 (1), pp. 51. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/epidemiology
Adult ; Humans ; Quality of Life ; Retrospective Studies ; Health Surveys ; Fatigue/epidemiology ; Fatigue/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors.
Autorzy:
Cárdenas-Robledo S; Centro de Esclerosis Múltiple (CEMHUN), Departamento de Neurología, Hospital Universitario Nacional de Colombia, Calle 44 # 59-75, Bogotá, Colombia. .; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. .
Arenas-Vargas LE; Centro de Esclerosis Múltiple (CEMHUN), Departamento de Neurología, Hospital Universitario Nacional de Colombia, Calle 44 # 59-75, Bogotá, Colombia.
Arenas RD; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Gaspar-Toro JM; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Muñoz-Rosero ÁM; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Tafur-Borrero AH; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Marín-Medina DS; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Acosta-Fajardo HA; Departamento de Medicina Interna, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.
Guío-Sánchez C; Centro de Esclerosis Múltiple (CEMHUN), Departamento de Neurología, Hospital Universitario Nacional de Colombia, Calle 44 # 59-75, Bogotá, Colombia.
López-Reyes L; Centro de Esclerosis Múltiple (CEMHUN), Departamento de Neurología, Hospital Universitario Nacional de Colombia, Calle 44 # 59-75, Bogotá, Colombia.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Apr 02; Vol. 24 (1), pp. 108. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
South American People*
Humans ; Female ; Adult ; Male ; Fingolimod Hydrochloride/therapeutic use ; Retrospective Studies ; Proportional Hazards Models
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Impact of Sample Storage on Blood Methylation: Towards Assessing Myelin Gene Methylation as a Biomarker for Progressive Multiple Sclerosis.
Autorzy:
Tiane A; Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, 6229 Maastricht, The Netherlands.; University MS Center (UMSC), 3500 Hasselt, Belgium.
Somers V; University MS Center (UMSC), 3500 Hasselt, Belgium.; Department of Immunology and Infection, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
Hellings N; University MS Center (UMSC), 3500 Hasselt, Belgium.; Department of Immunology and Infection, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.
van den Hove DLA; Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, 6229 Maastricht, The Netherlands.; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, 97080 Wuerzburg, Germany.
Vanmierlo T; Department of Neuroscience, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; Department Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, 6229 Maastricht, The Netherlands.; University MS Center (UMSC), 3500 Hasselt, Belgium.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 19; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 19.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/genetics
Multiple Sclerosis*/pathology
Multiple Sclerosis, Chronic Progressive*/pathology
Humans ; Myelin Sheath/pathology ; DNA Methylation ; Biomarkers ; Disease Progression
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis.
Autorzy:
Calabrò M; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Lui M; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Mazzon E; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
D'Angiolini S; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Mar 16; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis, Chronic Progressive*/genetics
Multiple Sclerosis*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/metabolism
Humans ; Brain/metabolism ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated?
Autorzy:
Bretscher PA; Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Heath Sciences Building, 105 Wiggins Road, Saskatoon, SK S5N 5E5, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 27; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Multiple Sclerosis*
Multiple Sclerosis, Relapsing-Remitting*
Humans ; Autoimmunity
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Plasma Lipidomic Profiling Using Mass Spectrometry for Multiple Sclerosis Diagnosis and Disease Activity Stratification (LipidMS).
Autorzy:
Lattau SSJ; Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Borsch LM; Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Auf dem Brinke K; Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Klose C; Lipotype GmbH, 01307 Dresden, Germany.
Vinhoven L; Department of Medical Bioinformatics, University Medical Center Göttingen, 37075 Göttingen, Germany.
Nietert M; Department of Medical Bioinformatics, University Medical Center Göttingen, 37075 Göttingen, Germany.
Fitzner D; Department of Neurology, University Medical Center Göttingen, 37075 Göttingen, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 20; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*
Multiple Sclerosis, Chronic Progressive*
Humans ; Lipidomics ; Lipids/chemistry ; Mass Spectrometry ; Phosphatidylethanolamines
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Siponimod Attenuates Neuronal Cell Death Triggered by Neuroinflammation via NFκB and Mitochondrial Pathways.
Autorzy:
Gurrea-Rubio M; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Wang Q; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Mills EA; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Wu Q; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Pitt D; Department of Neurology, Yale Medicine, New Haven, CT 06473, USA.
Tsou PS; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Fox DA; Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
Mao-Draayer Y; Department of Neurology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI 48109, USA.; Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 20; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroprotective Agents*/pharmacology
Multiple Sclerosis*/drug therapy
Multiple Sclerosis, Chronic Progressive*/drug therapy
Azetidines*
Benzyl Compounds*
Humans ; Animals ; Rats ; Sphingosine-1-Phosphate Receptors ; Neuroinflammatory Diseases ; Tumor Necrosis Factor-alpha/therapeutic use ; Cell Death
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.
Autorzy:
Kampaite A; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Imaging, Edinburgh Imaging Facility, University of Edinburgh, Edinburgh, United Kingdom.
Gustafsson R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
York EN; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Imaging, Edinburgh Imaging Facility, University of Edinburgh, Edinburgh, United Kingdom.; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.
Foley P; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.
MacDougall NJJ; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.; Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Bastin ME; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Imaging, Edinburgh Imaging Facility, University of Edinburgh, Edinburgh, United Kingdom.
Chandran S; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.; UK Dementia Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Waldman AD; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Imaging, Edinburgh Imaging Facility, University of Edinburgh, Edinburgh, United Kingdom.
Meijboom R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.; Edinburgh Imaging, Edinburgh Imaging Facility, University of Edinburgh, Edinburgh, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 29; Vol. 19 (3), pp. e0299634. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Multiple Sclerosis, Relapsing-Remitting*/complications
Multiple Sclerosis, Relapsing-Remitting*/diagnostic imaging
Multiple Sclerosis, Relapsing-Remitting*/pathology
Multiple Sclerosis*
Humans ; Adolescent ; Depression/diagnostic imaging ; Quality of Life ; Brain/pathology ; Magnetic Resonance Imaging/methods ; Fatigue
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland.
Autorzy:
Kuri A; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK. .; Neurology and Neurosurgery Interest Group (NANSIG), London, UK. .
Henshall DE; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Deanery of Clinical Sciences, College of Medicine & Veterinary Medicine, The University of Edinburgh, Edinburgh, EH16 4SB, UK.
Chaudhry D; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Royal Stoke University Hospital, University Hospitals of North Midlands, Stoke-on-Trent, ST4 6QG, UK.
Ooi SZY; Neurology and Neurosurgery Interest Group (NANSIG), London, UK.; Cardiff University School of Medicine, Cardiff, CF14 4XN, UK.
Zhang Q; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Mathews J; Department of Neurology, Royal London Hospital, London, UK.
Thomson A; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Rog D; Department of Neurology, Manchester Centre for Clinical Neurosciences, Salford, Manchester, M6 8HD, UK.
Hobart J; Peninsula Medical School, Faculty of Health, University of Plymouth, Plymouth, PL6 8BT, Great Britain.
Dobson R; Wolfson Institute of Population Health, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Pokaż więcej
Corporate Authors:
Neurology and Neurosurgery Interest Group (NANSIG)
Źródło:
BMC neurology [BMC Neurol] 2024 Mar 28; Vol. 24 (1), pp. 105. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/epidemiology
Multiple Sclerosis*/drug therapy
Young Adult ; Humans ; Retrospective Studies ; Ireland/epidemiology ; United Kingdom/epidemiology ; Observational Studies as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017.
Autorzy:
Jendretzky KF; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Bajor A; Department of Ophthalmology, Hannover Medical School, Hannover, Germany.
Lezius LM; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Hümmert MW; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Konen FF; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Grosse GM; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Schwenkenbecher P; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Sühs KW; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Trebst C; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Framme C; Department of Ophthalmology, Hannover Medical School, Hannover, Germany.
Wattjes MP; Institute for Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany.
Meuth SG; Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Gingele S; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Skripuletz T; Department of Neurology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7293. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:
Journal Article
MeSH Terms:
Optic Neuritis*/diagnosis
Optic Neuritis*/pathology
Multiple Sclerosis*/complications
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/pathology
Demyelinating Diseases*/diagnosis
Humans ; Evoked Potentials, Visual ; Optic Nerve/diagnostic imaging ; Optic Nerve/pathology ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review and meta-analysis of socio-cognitive impairments in multiple sclerose.
Autorzy:
Roheger M; Department of Neurology, University Medicine Greifswald, Walther Rathenau Str. 49, 17489, Greifswald, Germany.; Ambulatory Assessment in Psychology, Department of Psychology, Carl Von Ossietzky University Oldenburg, Oldenburg, Germany.
Grothe L; Department of Neurology, University Medicine Greifswald, Walther Rathenau Str. 49, 17489, Greifswald, Germany.
Hasselberg L; Department of Neurology, University Medicine Greifswald, Walther Rathenau Str. 49, 17489, Greifswald, Germany.
Grothe M; Department of Neurology, University Medicine Greifswald, Walther Rathenau Str. 49, 17489, Greifswald, Germany. .
Meinzer M; Department of Neurology, University Medicine Greifswald, Walther Rathenau Str. 49, 17489, Greifswald, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 26; Vol. 14 (1), pp. 7096. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Cognitive Dysfunction*/epidemiology
Cognition Disorders*
Multiple Sclerosis*/complications
Multiple Sclerosis*/psychology
Humans ; Sclerosis ; Cognition
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
Autorzy:
Lereim RR; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Nytrova P; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Guldbrandsen A; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Havrdova EK; Department of Neurology and Center for Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
Myhr KM; Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Barsnes H; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.; Computational Biology Unit (CBU), Department of Informatics, University of Bergen, Bergen, Norway.
Berven FS; Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Bergen, Norway.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 25; Vol. 19 (3), pp. e0300914. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/cerebrospinal fluid
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Multiple Sclerosis, Relapsing-Remitting*/cerebrospinal fluid
Humans ; Natalizumab/therapeutic use ; Proteome ; Anti-Inflammatory Agents/therapeutic use ; Biomarkers/metabolism ; Immunologic Factors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effects of dry needling on spasticity, cortical excitability, and range of motion in a patient with multiple sclerosis: a case report.
Autorzy:
Choobsaz H; School of Rehabilitation, Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran.
Ghotbi N; School of Rehabilitation, Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran. .
Ansari NN; School of Rehabilitation, Department of Physiotherapy, Tehran University of Medical Sciences, Tehran, Iran.; Research Center for War-Affected People, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Mar 24; Vol. 18 (1), pp. 125. Date of Electronic Publication: 2024 Mar 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Cortical Excitability*
Multiple Sclerosis*/complications
Multiple Sclerosis*/therapy
Adult ; Female ; Humans ; Iran ; Muscle Spasticity/therapy ; Muscle Spasticity/etiology ; Percutaneous Collagen Induction ; Range of Motion, Articular/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.
Autorzy:
Brnabic AJM; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Curtis SE; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Johnston JA; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Lo A; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Zagar AJ; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Lipkovich I; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Kadziola Z; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Murray MH; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Ryan T; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 22; Vol. 19 (3), pp. e0300708. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/complications
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/epidemiology
Multiple Sclerosis, Relapsing-Remitting*/drug therapy
Cardiovascular Diseases*/drug therapy
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Renal Insufficiency, Chronic*/drug therapy
Crotonates*
Hydroxybutyrates*
Nitriles*
Toluidines*
Adult ; Humans ; Immunosuppressive Agents/therapeutic use ; Dimethyl Fumarate/therapeutic use ; Retrospective Studies ; Incidence ; NF-E2-Related Factor 2 ; Fingolimod Hydrochloride/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparison between stem cell therapy and stem cell derived exosomes on induced multiple sclerosis in dogs.
Autorzy:
Abdallah AN; Hormones Department, Medical Research and Clinical Studies Institute, National Research Center, Giza, Egypt.
Shamaa AA; Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
El-Tookhy OS; Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Bahr MM; Surgery, Anesthesiology and Radiology Department, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. .
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2024 Mar 08; Vol. 20 (1), pp. 90. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/veterinary
Multiple Sclerosis*/drug therapy
Exosomes*
Dog Diseases*/pathology
Dogs ; Animals ; Myelin Sheath/metabolism ; Myelin Sheath/pathology ; Stem Cells ; Cell- and Tissue-Based Therapy/veterinary
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.
Autorzy:
Kodosaki E; UK Dementia Research Institute at University College London, London, WC1E6BT, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N3BG, UK.; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.
Watkins WJ; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Loveless S; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.
Kreft KL; Department of Neurology, University Hospital of Wales, Cardiff, UK.
Richards A; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.
Anderson V; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.
Hurler L; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, 1085, Hungary.
Robertson NP; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.; Department of Neurology, University Hospital of Wales, Cardiff, UK.
Zelek WM; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
Tallantyre EC; Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK. .; Department of Neurology, University Hospital of Wales, Cardiff, UK. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2024 Feb 17; Vol. 21 (1), pp. 52. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Multiple Sclerosis*/cerebrospinal fluid
Chitinases*
Humans ; Osteopontin ; Vitamin D-Binding Protein ; Biomarkers/cerebrospinal fluid ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis.
Autorzy:
Bagnoud M; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Remlinger J; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Joly S; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Massy M; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
Salmen A; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Chan A; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Karathanassis D; Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Evangelopoulos ME; Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Hoepner R; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Department of Biomedical Research, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2024 Feb; Vol. 30 (2), pp. e14484. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/drug therapy
Multiple Sclerosis*/genetics
Metabolism, Inborn Errors*
Receptors, Glucocorticoid/*deficiency
Humans ; Glucocorticoids/pharmacology ; Glucocorticoids/therapeutic use ; Receptors, Glucocorticoid/genetics ; Chronic Disease ; Gene Expression Profiling ; Recurrence
SCR Disease Name:
Glucocorticoid Receptor Deficiency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
Autorzy:
Abdelhak A; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California, USA.; Department of Neurology, University Hospital of Ulm, Ulm, Germany.
Antweiler K; Department of Medical Statistics, University Medical Centre Göttingen, Göttingen, Germany.
Kowarik MC; Department of Neurology and Stroke, University Hospital of Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Senel M; Department of Neurology, University Hospital of Ulm, Ulm, Germany.
Havla J; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University, Munich, Germany.
Zettl UK; Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.
Kleiter I; Marianne-Strauß-Klinik, Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gGmbH, Berg, Germany.
Skripuletz T; Department of Neurology, Hannover Medical School, Hanover, Germany.
Haarmann A; Department of Neurology, University Hospital Würzburg, Würzburg, Germany.
Stahmann A; Forschungs- und Projektentwicklungs-gGmbH, MS-Registry by the German MS-Society, Hanover, Germany.
Huss A; Department of Neurology, University Hospital of Ulm, Ulm, Germany.
Gingele S; Department of Neurology, Hannover Medical School, Hanover, Germany.
Krumbholz M; Department of Neurology and Stroke, University Hospital of Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; Department of Neurology and Pain Treatment, Multiple Sclerosis Center, Center for Translational Medicine, Immanuel Klinik Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.; Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.
Benkert P; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Biomedicine, University Hospital and University of Basel, Basel, Switzerland.; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland.; Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
Friede T; Department of Medical Statistics, University Medical Centre Göttingen, Göttingen, Germany.
Ludolph AC; Department of Neurology, University Hospital of Ulm, Ulm, Germany.; German Center for Neurodegenerative Diseases, Ulm, Germany.
Ziemann U; Department of Neurology and Stroke, University Hospital of Tübingen, Tübingen, Germany.; Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Kümpfel T; Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig-Maximilians University, Munich, Germany.
Tumani H; Department of Neurology, University Hospital of Ulm, Ulm, Germany.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Feb; Vol. 11 (2), pp. 477-485. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Multiple Sclerosis*
Multiple Sclerosis, Chronic Progressive*/diagnosis
Female ; Humans ; Middle Aged ; Biomarkers ; Glial Fibrillary Acidic Protein ; Intermediate Filaments ; Neoplasm Recurrence, Local ; Male
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The relationship between dietary profile and adherence to the Mediterranean diet with EDSS and quality of life in multiple sclerosis patients: a retrospective cross-sectional study.
Autorzy:
Uygun Özel S; Department of Nutrition and Dietetics, Baskent University, Ankara, Turkey.
Bayram S; Department of Nutrition and Dietetics, Baskent University, Ankara, Turkey.
Kılınç M; Department of Neurology, Baskent University, Ankara, Turkey.
Pokaż więcej
Źródło:
Nutritional neuroscience [Nutr Neurosci] 2024 Apr; Vol. 27 (4), pp. 404-412. Date of Electronic Publication: 2023 Apr 18.
Typ publikacji:
Journal Article
MeSH Terms:
Multiple Sclerosis*/diagnosis
Diet, Mediterranean*
Male ; Female ; Humans ; Quality of Life ; Cross-Sectional Studies ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 173259

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies